Antisense oligonucleotides for ICAM-1 attenuate reperfusion injury and renal failure in the rat. The leukocyte adhesion molecule ICAM-1 is implicated in ischemic renal reperfusion injury. We tested the utility of an TCAM-1 antisense oligodeoxyribonucleotide (ODN) with lipofectin, six hours prior to 30 minutes of bilateral renal ischemia in the rat. We measured ICAM-1 expression by immunohistochemistry and Western blot. Our antisense ODN showed a specific ICAM-1 surface expression inhibition in vitro. We then assessed ICAM-1 expression, leukocyte infiltration, serum creatinine, serum urea concentration, and renal histology in rats subjected to renal ischemia and controls. Serum creatinine and urea concentrations 12 and 24 hours post-ischemia were increased in saline treated and reverse ODN treated rats, compared to antisense ODN treated or sham operated rats (P < 0.05). Western blotting showed decreased ICAM-1 protein in antisense ODN-treated kidneys, compared to reverse ODN treated and saline treated ischemic controls (P < 0.05). Antisense ODN also ameliorated the ischemia-induced infiltration of granulocytes and macrophages (P < 0.05), and resulted in less cortical renal damage as assessed by a quantitative pathological grading scale (P < 0.05), compared to reverse ODN or saline treatment. Thus, antisense ODN for ICAM-1 protected the kidney against ischemic renal failure. The clinical applicability of these findings extends beyond ischemic acute renal failure.
injury and protected renal function [17, i8] . However, antibody treatment has inherent problems that could be circumvented with antisense oligonucleotides. We tested the hypothesis that ICAM-1 antisense oligonucleotides can inhibit ICAM-1 expression in the ischemic kidney, prevent neutrophil adhesion and infiltration, and thereby ameliorate ischemia-induced renal failure.
Methods

Oligonucleotides
Phosphorothioate oligodeoxyribonucleotides (ODN) were purchased (Tib Molbiol, Berlin, Germany). We selected an antisense ODN (ISIS 1939) against the human 3' untranslated region derived from the rat ICAM sequence RSICAM and the human ICAM-1 sequence HSICAMO1 (European Molecular Biology Laboratories data base, Heidelberg, Germany) [19, 20] . For the rat experiments, we compared rat and human sequence data and used the rat homologue to ISIS 1939 (5' ACC GGA TAT CAC ACC TIC CT 3'). The reverse ODN sequence was used as control. We used a cationic lipid solution (Lipofectin; GIBCO BAL, Life Technologies, Hamburg, Germany) to enhance the ODN uptake. In the in vitro experiments, lipofectin was added five minutes prior to the ODN application, while in the animal experiments ODN and lipofectin were added together.
Animal protocol
Male Sprague-Dawley rats (Ivanovas, Kisslegg, Germany) aged 12 weeks, were maintained in cages at 24 2°C and were given tap water and a standard rat diet (C-1000; Altromin, Lage, Germany) containing 0.2% sodium by weight. They were fasted 12 hours before surgery. After thiohexital (Brevimytal; Bayer, Leverkuesen, Germany) anesthesia, a cathether was placed in the right femoral artery and vein. Lipofectin solution (1 ml) containing antisense ODN, reverse ODN control, lipofectin control, or 0.9% saline control were administered to four groups of 12 rats each, via the venous catheter six hours prior to ischemia. We also included a sham-operated saline-injected group and a shamoperated lipofectin-injected group to control for any operative, or lipofectin-induced effects. Finally, we included a group of rats that were sacrificed to determine basal ICAM-1 expression in nonanesthetized, nonmanipulated rats. Ischemic injury was induced in anesthetized rats by clamping the left and right renal hila with microaneurysm clamps for 30 minutes after a bilateral flank The excised kidneys were divided with forceps and scissors into medulla and cortex. The tissue slices were treated with ice cold buffer (10 mrvi Tris-HCI pH 7.4, 100 mvi NaCI, 300 mivi sucrose, I mM EDTA, 0.2 mrvi PMSF, I jig/mI leupeptin, 0.5% Triton X-100, 0.2% NaN3) and immediately homogenized. The homogenate was then spun at 13 000 g for five minutes and the supernatant was incision. Blood samples (0.5 ml) for urea and creatinine determi-of ICAM-1 on cultured endothelial cells we used a modified nation were obtained from the femoral arterial cathether at -6, 0, ELISA protocol [21] . 12, and 24 hours after reperfusion. Rats were killed under chloral hydrate anesthesia and the kidneys removed at 12 and 24 hours. collected. After determination of protein content, the immunoblotting was carried out as previously published [22] . Briefly, 25 jxg of each sample were run on a 10% polyacrylamide gel and electro-blotted onto a Poly-Screen PVDF Transfer Membrane and in the renal medulla (s). Treatment with antisense ODN prevented the ischemia-induced increase in ICAM-1 expression both in the vasculature and in the peritubular area. Reverse ODN had no effect. *P < 0.05.
described protocol (Serva, Heidelberg, Germany). The signal was quantified densitometrically with a Biorad (Freiburg, Germany) video densitometer 620. The signals were then integrated and the results were expressed in arbitrary units.
Immunohistochemistiy and pathology Immunohistochemistry was carried Out as previously described [23] . For immunohistochemical staining, the sections were incubated with the monoclonal antibody anti-rat ICAM-1, clone 1A29, (Medac, Hamburg, Germany), monoclonal antibody anti-rat monocytes, clone ED 1, (Camon, Wiesbaden, Germany) monoclonal antibody anti-rat granulocytes, clone His 48, (Dianova, Hamburg, Germany) and diluted in RPMI (Seromed, Heidelberg, Germany) for 30 minutes at room temperature in a humid chamber. After washing with TBS, the sections were incubated with a rabbit anti-mouse bridging antibody (Dako, Hamburg, Germany). The immunoreactivity was visualized with an alkaline phosphatase antialkaline phosphatase (APAAP) complex (Dako). For detection and development we used the neufuchsin-naphtholAs-Bi-phosphate substrate (Merck, Darmstadt, Germany) as described.
Semiquantitative data on the ICAM-1 expression were obtained by measuring the gray values of the film autoradiograms using the microdensitometrical program of the IBAS 2.5 (Kontron, Konstanz, Germany) according to a previously published microdensitometric method [23] . The autoradiograms were digitized directly via a television camera (CCD 72/MTi-camera) on a screen, allowing the measurement of an entire section at once. Transmissions as well as optical densities were obtained utilizing post-processing programs.
The degree of leukocyte infiltration was determined by visually counting the stained granulocytes and monocytes, respectively, in the perivascular areas across kidney sections, as described previously [23] . To quantify the results we used a grading scale in which 0 indicated that no infiltrating cells were present, I indicated that one to four infiltrating leukocytes were identified, and 2 indicated infiltrates of 5 or more cells. The infiltrates were expressed as % of the vessels analyzed. Kidneys from six animals in each group were used for this purpose. Multiple sections were examined, so that at least 50 separate vessels were evaluated from each of the three groups.
Six half kidneys from each group at both 12 and 24 hours were sectioned, fixed in formalin, and stained with hematoxylin and eosin as described for our laboratory previously [24] . Without knowledge of the regimens, sections from each kidney were evaluated by a pathologist. Tubular necrosis was assessed with a quantitative grading scale (0 to 3) corresponding to none, mild, moderate, or severe necrosis as outlined elsewhere [241. Cell swelling, vacuolization, nuclear pyknosis, necrosis and cellular infiltrate were evaluated. Nonparametric (Wilcoxon test) and parametric (2 way ANOVA) were used as appropriate. P c 0.05 was considered significant.
Results
To select the most effective lipofectin concentration for the gene transfer, we examined lipofectin concentrations ranging from 0.1 to 5 mg/mg DNA on TNF-a induced expression of ICAM-1. The endothelial cells were incubated with increasing concentrations of lipofectin for four hours. Antisense oligonucleotides inhibited the TNF-n induced ICAM-1 expression (P < 0.01) at all concentrations used, while reverse oligonucleotides had only a minor, nonsignificant effect. At lipofectin concentrations 0.1 to 0.5 mg/mg DNA, we observed only a slight, nonsigificant inhibition of TNF-a induced ICAM-1 expression, while concentrations of 0.8 mgImgDNA inhibited ICAM-1 effectively.
Lipofectin at 2 mg/mg DNA damaged the cells. From these experiments, a lipofectin concentration of 0.8 mg/mg DNA and a ODN concentration of 2 mg/kg body wt was chosen for the in vitro studies. Figure 1A shows the effect of reverse and antisense oligonucleotides on expression of ICAM-1 in renal cortical vessels 24 hours after 30 minutes of ischemia. The saline injected control showed ICAM-1 staining along the vascular intima. This staining was decreased in antisense ODN treated animals. The reverse ODN treated animals, on the other hand, showed prominent ICAM-1 staining. Figure lB shows the corresponding densitometric analysis. Saline and reverse ODN treatment showed similar densities, while the antisense ODN treated animals showed significantly less ICAM-1 staining density. Figure 2A shows the Western blotting of these same kidneys for ICAM-l protein. Both the renal cortex and medulla from saline treated and reverse ODN treated rats showed prominent amounts of ICAM-1, while the antisense ODN treated animals showed significantly less amounts of ICAM-1. Optical density (Fig. 2B) illustrates the significant differences between these groups. ICAM-1 expression in nonischemic sham operated, saline, or lipofectin treated animals was not absent compared to unmanipulated control rats. We observed a detectable increase in ICAM-1 expression in kidneys from these rats, indicating that the manipulation itself up-regulates ICAM-1 (optical densities in arbitrary units 11.9 1.3 vs. 8. 5 1.7 in the medulla; 12.4 1.5 vs. 8.6 2.3 in the cortex). We found no difference between lipofectin and saline treated, sham operated animals. Figure 3 shows the effects on renal function. Creatinine (Fig.  3A) and urea (Fig. 3B ) concentrations in serum increased by 12 hours and 24 hours in rats with ischemia treated with saline or with reverse ODN, compared to rats given antisense ODN. Sham operated rats had no increase in creatinine or urea concentrations, compared either to baseline values or to values from unmanipulated rats (not shown). Figure 4A shows the effect on perivascular granulocyte infiltration at 12 hours as shown by immunohistochemistry. Salinetreated ischemic rat kidneys showed considerable granulocyte staining, which was more prominent than in the antisense ODN group. Reverse ODN treatment, on the other hand, did not ameliorate the granulocyte infiltration. Granulocyte infiltration was found in only 23 vessels in antisense treated kidneys, compared to 56 in untreated ischemic kidneys and 57 in kidneys treated with reverse ODN (P < 0.05). We also quantified the numbers of infiltrates (Fig. 4B) . Granulocyte infiltrates were significantly reduced by antisense treatment (P < 0.05), while reverse ODN did not influence the ischemia-induced granulocyte infiltration.
We conducted the same immunohistochemical staining and quantitative evaluation for monocytes. Figure 5A shows the monocyte perivascular staining in the renal cortex from ischemic animals with saline, compared to antisense ODN treated animals and reverse ODN treated animals. Monocytes around blood vessels were more frequent in the saline and reverse ODN treated sections, compared to the antisense ODN treated sections. Monocyte infiltration was found in 39 vessels of antisense treated kidneys, compared to 54 in untreated ischemic kidneys and 56 in kidneys treated with reverse ODN (P < 0.05). We also quantified the numbers of infiltrates (Fig. SB) . Monocyte infiltrates were significantly reduced by antisense treatment (P < 0.05), while reverse ODN did not influence the ischemia-induced granulocyte infiltration.
Representative hematoxylin and eosin renal cortical sections from saline treated, antisense ODN treated, and reverse ODN treated rats subjected to renal ischemia are shown in Figure 6 . Rats with saline treated (Fig. 6, left) and reverse ODN treated (Fig. 6, right) renal ischemia showed moderate to severe necrosis. The sections show tubular cell swelling, cellular vacuolization, pyknotic nuclei, and round cell infiltration. Rats treated with antisense ODN (Fig. 6, middle) showed prominent cell swelling but only mild necrosis. Only a few pyknotic nuclei were observed, and the round cell infiltration was less than in the other two groups. Analysis of the grading scales revealed signficantly less severe renal cortical damage in kidneys from antisense ODN treated animals compared to the other two ischemic groups.
Discussion
We were successful in inhibiting ICAM-1 expression in endothelial cells in vitro with antisense ODN [25] . We used these results to estimate the lipofectin and antisense ODN concentrations necessary to inhibit ICAM-1 expression in the rat with renal ischemia. We found that antisense ODN indeed inhibited ICAM-1 expression in vivo, and that it also ameliorated acute renal failure according to functional and histological criteria. The inhibited ICAM-1 expression was associated with decreased vascular infiltration of both granulocytes and monocytes, which supports the conclusion that adhesion molecules are important in the genesis of ischemic acute renal failure. We believe that our conclusions are supported by the fact that we showed the effect of antisense treatment on ICAM-1 expression, production, and effect in terms of leukocyte infiltration, as well as demonstrating an effect on renal histology and function.
Our finding that ICAM-1 is important in reperfusion injury is not new. Antibodies directed against ICAM-1 effectively block its role in cell-to-cell adhesion and can ameliorate ischemic reperfusion injury in several animal models [10, 15, 17, 18, [26] [27] [28] . A modest but detectable up-regulation of ICAM-1 was present in our sham operated rats, indicating the sensitivity of the cell-to-cell adhesion mechanism. However, our purpose was not to retest this hypothesis. Instead, we sought to develop a novel, nonantibody means of blocking ICAM-1 expression in vivo to specifically ameliorate ischemic reperfusion injury. We used a phosphorothioate-stabilized ODN against the 3' untranslated region of ICAM-1.
Bennett and coworkers have previously shown that antisense ODN against this region are highly specific and very effective [25] . with regard to specificity of the inhibitory effect of phosphothiorate ODN [29] . Our results support the notion that phosphorothioate ODN against endothelial adhesion molecules are a specific therapeutic tool.
To enhance ODN uptake we used the cationic lipid preparation, lipofectin. We established the optimal dose in the in vitro transplant medicine. In experimental animals, both renal isografts and kidneys exposed to transient ischemia show a long-term course of progressive proteinuria and gradual renal failure [32] . Thus, initial damage appears to foster a subsequent decline, even if conventional rejection mechanisms are not involved. Cadaveric donor kidneys are routinely stored in Collins or similar solutions for 12 to 72 hours before transplantation.Delayed graft function from ischemia and reperfusion injury is a major post-transplant problem and has a direct negative impact on long-term graft survival [33] . Transplanted hearts and livers also are subject to reperfusion injury and ICAM-1 seems to play a role in acute and chronic rejection [34] [35] [36] [37] [38] . The antisense ODN treatment could avoid any potential immunological problems that might accompany the use of antibodies directed against adhesion molecules, particularly if the therapy is required more than once [20] . We would envision a multiple antisense ODN treatment of transplant grafts directed against a variety of adhesion molecules associated with reperfusion injury and are currently pursuing experimental studies of this nature. Finally, we believe the ODN approach opens new avenues to investigate pathogenetic mechanisms involved in acute renal failure and other renal diseases. experiments, but nevertheless included a sham operated lipofectin control, since we had observed some renal damage from lipofectin in earlier studies (unpublished observations). The low concentration of lipofectin used raises the question whether "naked" ODN might have been successfully used to suppress protein expression [20] . However, in preliminary experiments we were not able to achieve significant inhibition of ICAM-1 without lipofectin in vitro. Since lipofectin did exhibit some toxicity at higher doses, a "concentration window" for the appropriate transfer enhancement for antisense ODN in viva may be important. A detailed consideration of vehicles in gene transfer is beyond the scope of this discussion; however, we are evaluating liposomes with viral fusion proteins as a potentially less toxic and more efficient transfer approach.
